SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (20762)4/18/1999 4:02:00 PM
From: DAVID  Read Replies (1) | Respond to of 23519
 
<<Sit back and enjoy. Too much good news coming out for a small cap stock with a 20% short interest between now and the June 8 annual share holder's meeting not to watch with a smile on your face.>>

Vlad,

I am still trying to be optimistic about Vivus. I was caught in the Dec 97 gap down and have averaged down.

What concerns me is the analysts estimates. FY99 $0.20/share. If we will have a $0.12 Q1 and similar for Q2 due to milestone payments, I can only imagine what will happen for Q3 and Q4.

Any comments or estimates ?

DAVID




To: VLAD who wrote (20762)4/18/1999 5:00:00 PM
From: Curtis Frazier  Read Replies (1) | Respond to of 23519
 
Well, we will see. We already know the earnings report will not affect the stock price. We just have to see what is in the Conference Call. Only time will tell us. Next week will be interesting. Unless we have some SALES, we will just have to sit and wait. Just like I'm doing with GNTA.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News